Pfizer-BioNTech Covid-19 Candidate Shows ‘Positive’ Data; Analyst Sticks To Hold

Pfizer Inc. and BioNTech SE disclosed positive data from an early trial of their BNT162b2 mRNA-based vaccine candidate against SARS-CoV2 and confirmed that they were on track to seek regulatory revie…
Read More